Skip to main content

Table 1 Functions of Jun and Fos proteins

From: Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease

Activator protein 1 protein

Phenotype

Affected organs/cells

Transgenic

  

   H2Kb-Jun

None

None

   Ubiquitin C-JunBa

Increased bone mass

Not defined

   CD4-JunB

Enhanced T helper cell 2 maturation

Thymus, CD4 thymocytes

   Ubiquitin C-JunD

Peripheral T cells and B cells reduced

Lymphocytes

   H2Kb-Fos

Osteosarcoma

Bone, osteoblasts

   H2Kb-Fos/Rsk-2-/y

Reduced osteosarcoma

Bone, osteoblasts

   H2Kb-FosB

None

Bone

   TCRβ-ΔFosB

Impaired T cell differentiation

Thymus, immature thymocytes

   NSE-ΔFosB

Osteosclerosis

Bone, osteoblasts

   H2Kb-Fra-1

Osteosclerosis

Bone, osteoblasts

   CMV-Fra-2

Occular malformations

Anterior eye structure

   H2Kb-Fra-2a

Increased bone mass, fibrosis

Bone, internal organs, skin

Knockout

  

   Jun

Embryonic lethal on embryonic day 12.5

Liver, heart, neural crest

   JunB

Embryonic lethal on embryonic day 10

Extraembryonic tissues

   JunD

Male sterility

Testis, spermatides

   c-Fos

Osteopetrosis

Bone, osteoclasts

   FosB

Nurturing defect

Brain, hypothalamus

   Fra-1

Embryonic lethal on embryonic day 9.5

Extraembyonic tissue

   Fra-2

Lethal at birth

Bone, osteoclasts

Conditional

  

   Alfp-cre Jun

Liver regeneration defect

Liver, hepatocytes

   Col2a1-cre Jun

Scoliosis

Bone, notochordal cells

   Nestin-cre Jun

Axonal regeneration defect

Central nervous system, motoneurons

   MORE-cre JunB

Osteopenia

Bone, osteoclasts, osteoblasts

   K5-cre Jun

Eyes open at birth, reduced skin tumors

Keratinocytes

   Nestin-cre Fos

Learning defects

Brain, hippocampal neurons

   MORE-cre Fra-1

Osteopenia

Bone, osteoblasts

Inducible

  

   K5-creERTJunB + Jun

Psoriasis-like disease

Skin, joints, keratinocytes

  1. Knockout, conditional knockout and gain of function (transgenic) approaches applied to study the role of Jun and Fos proteins during development and in diseases. The gain-of-function approaches were performed with different promoters, either leading to ubiquitous expression (for example, H2Kb, ubiquitin C, or cytomegalovirus (CMV)) or to tissue-specific expression (for example, CD4, TCRβ, or neuron-specific enolase (NSE)) of the transgenes. aUnpublished data from the Wagner Laboratory.